Back to Articles
Tax & ComplianceTaxGuru

Business | Zydus and Formycon’s Keytruda® biosimilar accepted for USFDA review

13 Oct 2026 · 1d agoBy TG TeamSource: TaxGuru

Read the Zydus Lifesciences Limited announcement filed with the NSE, with the key figures and what it means for shareholders. The post Zydus and Formycon’s Keytruda® biosimilar accepted for USFDA review appeared first on TaxGuru .

Attribution

Original credit: TG Team. This digest is published with acknowledgment to TaxGuru. For the complete analysis, headnotes, and citations, please refer to the source.

Read on TaxGuru

More Articles